Aclaris Therapeutics, Inc. ( ACRS) - Key Metrics
ACRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.16 | -$0.11 | -$0.11 |
| 2025Q3 | $0.03 | -$0.12 | -$0.09 | -$0.09 |
| 2025Q2 | $0.01 | -$0.13 | -$0.08 | -$0.08 |
| 2025Q1 | $0.01 | -$0.12 | -$0.11 | -$0.11 |
ACRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -4.66 |
| 2025Q3 | ? | -3.99 |
| 2025Q2 | ? | -2.82 |
| 2025Q1 | ? | -3.10 |
ACRS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.76% | ? |
| 2025Q4 | -3.56% | ? |
| 2025Q3 | -4.70% | ? |
| 2025Q2 | -5.75% | ? |
| 2025Q1 | -7.00% | ? |
ACRS
Price: $4.42
52 week price:
Earnings Per Share: -0.56 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 2.0 million
Ebitda: -18.6 millionMarket Capitalization: 533.0 million